UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
UBS Reiterates a 'Buy' on Gilead Sciences (GILD); Survey: ART Switching Should Increase
-
UBS Maintains a 'Buy' on Gilead Sciences (GILD); Our Top Near-term Idea in Large-Cap
-
UBS Maintains a 'Buy' on Gilead Sciences (GILD); Updated Quad Pill Clinical Trial Analysis Suggests Several Derivative Strategies
-
Notable Analyst Rating Changes 11/16: CAT, CREE, S, BRCD Upgraded; NLST, BUCY, PWRD, JOYG Downgraded
-
UPDATE - UBS Initiates Coverage on Gilead Sciences (GILD) with a Buy; HIV Franchise Has Staying Power:
-
UBS Initiates Coverage on Biotechnology Stocks (CELG, GILD, AMGN & BIIB)
-
UBS Starts Gilead Sciences (GILD) at Buy
-
Notable Analyst Rating Changes 09/09: AUO, LYG, INFN, NTAP Upgraded; SEH, SLAB, MPEL, ARNA Downgraded
-
Notable 52-Week High's and Low's of the Day 07/21: CRUS, VMW, CPX, VSAT High; GILD, GCA, CMTL, HBHC Low
-
Trading Radar for 01/26: Yahoo! (YHOO), W.W. Grainger (GWW), A.O. Smith (AOS), Delta Air Lines (DAL), Sherwin-Williams (SHW) Report
-
Stocks That Could Rise As Cases Of The Swine Flu Increase (RAD, GENZ, GILD, UTHR, XRAY)
-
Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
-
Trading Radar for 7/21: Apple (AAPL), Merck (MRK), Coca-Cola (KO), Cat (CAT), Freeport-McMoRan (FCX), Yahoo! (YHOO), State Street (STT), BlackRock (BLK), Amylin (AMLN), Starbucks (SBUX) Report
-
David Moenning's Daily State of the Markets: 7/10
-
David Moenning’s Daily State of the Markets: 6/26
-
Swine Flu Stocks Poised To Rally (APT, HEB, AVII, CBMX, CRXL, SNY, BCRX, NVAX)
-
Trading Radar for 4/21: Yahoo! (YHOO), Coke (KO), US Bancorp (USB), Cat (CAT), Bank of NY Mellon (BK), DuPont (DD), Lockheed Martin (LMT), Schering-Plough (SGP), AMD (AMD), State Street (STT) Report
-
Gilead Sciences (GILD) to Acquire CV Therapeutics (CVTX) for $20/Share
-
David Moenning's Daily State of the Markets: 1/28
-
David Moenning's Daily State of the Markets: 12/16
-
Notable Analyst Rating Changes 12/16: BIDU, POT, MOS, KR, GILD Upgraded; UPS, GPS, LEN, WFMI Downgraded
-
David Moenning's Daily State of the Markets: 11/12
-
David Moenning's Daily State of the Markets: 10/17
-
Notable Analyst Rating Changes 9/12: WM, GILD, LCC, PBG Upgraded; BBY, BWLD, DHR Downgraded
-
Notable Analyst Rating Changes 9/2: AMLN, LOW, GOOG Upgraded; GILD, DF, NSC Downgraded
-
David Moenning's Daily State of the Markets: 9/2
-
Notable Analyst Rating Changes 8/28: AMLN, BT, JAS Upgraded; KO, CHL, GILD Downgraded
-
David Moenning's Daily State of the Markets: 8/28
-
David Moenning's Daily State of the Markets: 4/17
-
David Moenning's Daily State of the Markets: 2/22
-
David Moenning's Daily State of the Markets: 1/30
-
David Moenning's Daily State of the Markets:
-
David Moenning's Daily State of the Markets: 01/07
